CLONAZEPAM | A075150 | AUROBINDO PHARMA USA INC
Highest NADAC/Unit
$0.0378
per ea
Lowest NADAC/Unit
$0.0199
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 59651072401CLONAZEPAM 2 MG TABLET | $0.0378 | EA | Generic | — | 2026-06-17 |
| 59651072405CLONAZEPAM 2 MG TABLET | $0.0378 | EA | Generic | — | 2026-06-17 |
| 59651072301CLONAZEPAM 1 MG TABLET | $0.0250 | EA | Generic | — | 2026-06-17 |
| 59651072399CLONAZEPAM 1 MG TABLET | $0.0250 | EA | Generic | — | 2026-06-17 |
| 59651072201CLONAZEPAM 0.5 MG TABLET | $0.0199 | EA | Generic | — | 2026-06-17 |
| 59651072299CLONAZEPAM 0.5 MG TABLET | $0.0199 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.